Medpace Holdings Inc (MEDP)
NASDAQ · Healthcare · Diagnostics & Research
Medpace Holdings Inc is a Healthcare company with a market capitalization of $15.93B and a trailing P/E ratio of 33.6.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | April 22, 2026 | $4.28 | $3.96 | +8.1% |
| Q4 2025 | February 9, 2026 | $4.67 | $4.18 | +11.7% |
| Q3 2025 | October 22, 2025 | $3.86 | $3.57 | +8.1% |
| Q2 2025 | July 21, 2025 | $3.10 | $3.00 | +3.3% |
| Q1 2025 | April 21, 2025 | $3.67 | $3.07 | +19.5% |
| Q4 2024 | February 10, 2025 | $3.68 | $3.12 | +18.1% |
Short Interest
FINRA-reported short interest for semi-monthly settlement dates, published about nine business days after each settlement. Share counts are adjusted to the current split basis.
| Settlement | Shares Short | % of Shares Out | Days to Cover | Change |
|---|---|---|---|---|
| July 15, 2026 | 2,190,722 | — | 7.3 | +3.1% |
| June 30, 2026 | 2,125,118 | — | 5.9 | +1.9% |
| June 15, 2026 | 2,086,547 | — | 8.4 | +1.5% |
| May 29, 2026 | 2,054,885 | — | 6.7 | +7.9% |
| May 15, 2026 | 1,904,860 | — | 5.5 | +22.8% |
| April 30, 2026 | 1,550,758 | — | 2.5 | +15.1% |
| April 15, 2026 | 1,347,526 | — | 4.1 | +10.5% |
| March 31, 2026 | 1,219,606 | — | 4.1 | -12.9% |
Other Diagnostics & Research Stocks
Frequently Asked Questions
What is Medpace Holdings Inc's market cap?
As of August 13, 2026, Medpace Holdings Inc (MEDP) has a market capitalization of $15.93B.
What is Medpace Holdings Inc's P/E ratio?
Medpace Holdings Inc trades at a trailing price-to-earnings (P/E) ratio of 33.6. Its forward P/E is 33.2.
Does Medpace Holdings Inc pay a dividend?
Medpace Holdings Inc does not currently pay a dividend.
What sector is MEDP in?
Medpace Holdings Inc is in the Healthcare sector, specifically the Diagnostics & Research industry.
What is Medpace Holdings Inc's short interest?
As of the July 15, 2026 FINRA settlement, 2,190,722 MEDP shares were sold short. Days to cover: 7.3. FINRA publishes short interest twice a month, about nine business days after each settlement date.
What was Medpace Holdings Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), Medpace Holdings Inc reported revenue of $2.53B and net income of $451.12M.
Ask your own questions about MEDP
Try mrmarket.ai freeData as of August 13, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.